MCID: CBP001
MIFTS: 30

Cebpa-Associated Familial Acute Myeloid Leukemia

Categories: Cancer diseases, Genetic diseases

Aliases & Classifications for Cebpa-Associated Familial Acute Myeloid Leukemia

MalaCards integrated aliases for Cebpa-Associated Familial Acute Myeloid Leukemia:

Name: Cebpa-Associated Familial Acute Myeloid Leukemia 24
Familial Acute Myeloid Leukemia with Mutated Cebpa 71
Cebpa-Dependent Familial Acute Myeloid Leukemia 24

Characteristics:

GeneReviews:

24
Penetrance Analysis of pedigrees reported to date suggests that germline cebpa pathogenic variants exhibit high penetrance for the development of aml [nickels et al 2013, tawana et al 2015]. the penetrance of pathogenic variants may vary within and between families; data from ten families with germline cebpa pathogenic variants revealed that more than 80% of confirmed or presumed obligate adult heterozygotes have developed disease to date [tawana et al 2015].

Classifications:



External Ids:

UMLS 71 C3711382

Summaries for Cebpa-Associated Familial Acute Myeloid Leukemia

MalaCards based summary : Cebpa-Associated Familial Acute Myeloid Leukemia, also known as familial acute myeloid leukemia with mutated cebpa, is related to myeloid leukemia and leukemia. An important gene associated with Cebpa-Associated Familial Acute Myeloid Leukemia is CBFB (Core-Binding Factor Subunit Beta), and among its related pathways/superpathways are Endometrial cancer and NF-kappaB Signaling. Affiliated tissues include myeloid, bone marrow and bone, and related phenotypes are cellular and growth/size/body region

GeneReviews: NBK47457

Related Diseases for Cebpa-Associated Familial Acute Myeloid Leukemia

Diseases related to Cebpa-Associated Familial Acute Myeloid Leukemia via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 45)
# Related Disease Score Top Affiliating Genes
1 myeloid leukemia 25.3 TERT RUNX1 PICALM NUP214 NSD1 NPM1
2 leukemia 24.9 TERT SH3GL1 RUNX1 PICALM NSD1 NPM1
3 leukemia, acute myeloid 23.6 TERT SH3GL1 RUNX1 PICALM NUP214 NSD1
4 familial acute myeloid leukemia with mutated cebpa 11.8
5 acute myeloblastic leukemia without maturation 10.2 NPM1 FLT3
6 sm-ahnmd 10.2 KIT JAK2 CHIC2
7 cytogenetically normal acute myeloid leukemia 10.2 NPM1 FLT3 CEBPA
8 acute myeloblastic leukemia with maturation 10.1 NPM1 KIT FLT3
9 small intestine benign neoplasm 10.1 MLF1 KIT
10 myelodysplastic/myeloproliferative neoplasm 10.1 JAK2 FLT3 ETV6 DNMT3A
11 undifferentiated pleomorphic sarcoma 10.1 KRAS KIT
12 myeloid and lymphoid neoplasms associated with pdgfra rearrangement 10.1 KIT JAK2 ETV6 CHIC2
13 systemic mastocytosis 10.0 KIT JAK2 DNMT3A CHIC2
14 chronic leukemia 10.0 KIT JAK2 FLT3 DNMT3A
15 exanthem 10.0 KRAS KIT FLT3
16 myeloid sarcoma 10.0 NPM1 KIT FLT3
17 mastocytosis 10.0 KIT JAK2 FLT3 CHIC2
18 polycythemia vera 9.9 KIT JAK2 ETV6 DNMT3A
19 monocytic leukemia 9.9 RUNX1 MLLT10 FLT3
20 chronic eosinophilic leukemia 9.9 KIT JAK2 FLT3 ETV6 CHIC2
21 acute erythroid leukemia 9.9 PICALM JAK2 GATA2 CEBPA
22 8p11 myeloproliferative syndrome 9.9 RUNX1 KIT FLT3
23 atypical chronic myeloid leukemia 9.8 RUNX1 JAK2 ETV6
24 leukemia, acute lymphoblastic 3 9.8 RUNX1 FLT3 ETV6
25 acute myeloid leukemia with t(8;21)(q22;q22) translocation 9.8 RUNX1 KIT FLT3 CEBPA
26 gastrointestinal stromal tumor 9.8 KRAS KIT JAK2 FLT3
27 bone marrow cancer 9.8 NPM1 KIT JAK2 FLT3 DNMT3A
28 acute t cell leukemia 9.7 NUP214 MLLT10 LPP FLT3
29 acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) 9.6 RUNX1 KIT FLT3 ETV6 CBFB
30 blood platelet disease 9.6 RUNX1 KIT JAK2 FLT3
31 juvenile myelomonocytic leukemia 9.5 RUNX1 KRAS JAK2 FLT3 DNMT3A
32 leukemia, chronic lymphocytic 9.5 KRAS KIT JAK2 FLT3 DNMT3A
33 germ cell cancer 9.4 TERT KRAS KIT
34 precursor t-cell acute lymphoblastic leukemia 9.4 PICALM NUP214 MLLT10 FLT3 ETV6
35 myeloproliferative neoplasm 9.4 RUNX1 KIT JAK2 FLT3 ETV6 DNMT3A
36 wilms tumor 1 9.3 TERT NPM1 KRAS KIT FLT3 CEBPA
37 core binding factor acute myeloid leukemia 9.3 RUNX1 KRAS KIT JAK2 FLT3 CEBPA
38 myelofibrosis 9.0 RUNX1 NPM1 KIT JAK2 GATA2 FLT3
39 acute promyelocytic leukemia 8.9 TERT RUNX1 NPM1 KRAS FLT3 ETV6
40 leukemia, chronic myeloid 8.9 RUNX1 NPM1 KRAS KIT JAK2 GATA2
41 acute leukemia 8.8 RUNX1 MLLT10 KRAS KIT JAK2 GATA2
42 chronic myelomonocytic leukemia 8.8 RUNX1 NPM1 KRAS KIT JAK2 GATA2
43 hematologic cancer 8.5 RUNX1 PICALM NPM1 MLLT10 KIT JAK2
44 leukemia, acute lymphoblastic 8.4 RUNX1 PICALM MLLT10 KRAS KIT JAK2
45 myelodysplastic syndrome 7.3 TERT RUNX1 NUP214 NSD1 NPM1 MLF1

Graphical network of the top 20 diseases related to Cebpa-Associated Familial Acute Myeloid Leukemia:



Diseases related to Cebpa-Associated Familial Acute Myeloid Leukemia

Symptoms & Phenotypes for Cebpa-Associated Familial Acute Myeloid Leukemia

MGI Mouse Phenotypes related to Cebpa-Associated Familial Acute Myeloid Leukemia:

45 (show all 15)
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 10.47 CBFB CEBPA DNMT3A ETV6 FLT3 GATA2
2 growth/size/body region MP:0005378 10.34 CBFB CEBPA DNMT3A ETV6 FLT3 GATA2
3 hematopoietic system MP:0005397 10.32 CBFB CEBPA DNMT3A ETV6 FLT3 GATA2
4 embryo MP:0005380 10.3 CBFB DNMT3A ETV6 GATA2 JAK2 KIT
5 endocrine/exocrine gland MP:0005379 10.29 CBFB CEBPA DNMT3A ETV6 FLT3 GATA2
6 mortality/aging MP:0010768 10.28 CBFB CEBPA CHIC2 DNMT3A ETV6 FLT3
7 homeostasis/metabolism MP:0005376 10.27 CBFB CEBPA DNMT3A ETV6 FLT3 GATA2
8 cardiovascular system MP:0005385 10.25 CBFB CEBPA DNMT3A ETV6 GATA2 JAK2
9 immune system MP:0005387 10.25 CBFB CEBPA DNMT3A ETV6 FLT3 JAK2
10 integument MP:0010771 10.1 CBFB CEBPA CHIC2 ETV6 JAK2 KIT
11 liver/biliary system MP:0005370 10.07 CBFB CEBPA GATA2 JAK2 KIT KRAS
12 neoplasm MP:0002006 9.96 CBFB CEBPA ETV6 FLT3 JAK2 KIT
13 no phenotypic analysis MP:0003012 9.76 CBFB CEBPA ETV6 FLT3 KIT KRAS
14 normal MP:0002873 9.65 CBFB CEBPA ETV6 GATA2 JAK2 KIT
15 respiratory system MP:0005388 9.23 CBFB CEBPA JAK2 KIT KRAS RUNX1

Drugs & Therapeutics for Cebpa-Associated Familial Acute Myeloid Leukemia

Search Clinical Trials , NIH Clinical Center for Cebpa-Associated Familial Acute Myeloid Leukemia

Genetic Tests for Cebpa-Associated Familial Acute Myeloid Leukemia

Anatomical Context for Cebpa-Associated Familial Acute Myeloid Leukemia

MalaCards organs/tissues related to Cebpa-Associated Familial Acute Myeloid Leukemia:

40
Myeloid, Bone Marrow, Bone, T Cells, Small Intestine, Monocytes

Publications for Cebpa-Associated Familial Acute Myeloid Leukemia

Articles related to Cebpa-Associated Familial Acute Myeloid Leukemia:

(show all 30)
# Title Authors PMID Year
1
Disease evolution and outcomes in familial AML with germline CEBPA mutations. 24
26162409 2015
2
The role of different genetic subtypes of CEBPA mutated AML. 24
24056881 2014
3
Recognizing familial myeloid leukemia in adults. 24
23926458 2013
4
Concordant acute myeloblastic leukemia in monozygotic twins with germline and shared somatic mutations in the gene for CCAAT-enhancer-binding protein α with 13 years difference at onset. 24
23716546 2013
5
C/EBPa controls acquisition and maintenance of adult haematopoietic stem cell quiescence. 24
23502316 2013
6
Allogeneic stem cell transplant to eliminate germline mutations in the gene for CCAAT-enhancer-binding protein α from hematopoietic cells in a family with AML. 24
21455213 2011
7
First report of multiple CEBPA mutations contributing to donor origin of leukemia relapse after allogeneic hematopoietic stem cell transplantation. 24
21403128 2011
8
Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemia. 24
21134981 2011
9
Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity. 24
21177436 2011
10
Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations. 24
20439648 2010
11
A family harboring a germ-line N-terminal C/EBPalpha mutation and development of acute myeloid leukemia with an additional somatic C-terminal C/EBPalpha mutation. 24
19953636 2010
12
Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome. 24
20038735 2010
13
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. 24
19880497 2010
14
Hematopoietic stem cell expansion precedes the generation of committed myeloid leukemia-initiating cells in C/EBPalpha mutant AML. 24
19878871 2009
15
Complexity of CEBPA dysregulation in human acute myeloid leukemia. 24
19706798 2009
16
Another pedigree with familial acute myeloid leukemia and germline CEBPA mutation. 24
18946494 2009
17
Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favourable prognosis. 24
19277035 2009
18
Dysregulation of the C/EBPalpha differentiation pathway in human cancer. 24
19075268 2009
19
Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia. 24
18768433 2008
20
Cooperating gene mutations in acute myeloid leukemia: a review of the literature. 24
18288131 2008
21
Modeling of C/EBPalpha mutant acute myeloid leukemia reveals a common expression signature of committed myeloid leukemia-initiating cells. 24
18394553 2008
22
Familial myelodysplasia and acute myeloid leukaemia--a review. 24
18173751 2008
23
Transcriptional dysregulation during myeloid transformation in AML. 24
17934489 2007
24
AML patients with CEBPalpha mutations mostly retain identical mutant patterns but frequently change in allelic distribution at relapse: a comparative analysis on paired diagnosis and relapse samples. 24
16453003 2006
25
Further evidence that germline CEBPA mutations cause dominant inheritance of acute myeloid leukaemia. 24
15902292 2005
26
Mutation of CEBPA in familial acute myeloid leukemia. 24
15575056 2004
27
Evidence for allelic evolution of C/EBPalpha mutations in acute myeloid leukaemia. 24
14616999 2003
28
[Clinical and genetic background of familial myelodysplasia and acute myeloid leukemia]. 61
26876264 2016
29
Inherited predisposition to acute myeloid leukemia. 61
25311743 2014
30
CEBPA-Associated Familial Acute Myeloid Leukemia (AML) 61
20963938 2010

Variations for Cebpa-Associated Familial Acute Myeloid Leukemia

Expression for Cebpa-Associated Familial Acute Myeloid Leukemia

Search GEO for disease gene expression data for Cebpa-Associated Familial Acute Myeloid Leukemia.

Pathways for Cebpa-Associated Familial Acute Myeloid Leukemia

GO Terms for Cebpa-Associated Familial Acute Myeloid Leukemia

Cellular components related to Cebpa-Associated Familial Acute Myeloid Leukemia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 nucleoplasm GO:0005654 10 TERT RUNX1 NUP214 NSD1 NPM1 MLLT10
2 focal adhesion GO:0005925 9.55 NUP214 NPM1 LPP KRAS JAK2
3 nucleus GO:0005634 9.53 TERT RUNX1 PICALM NUP214 NSD1 NPM1
4 core-binding factor complex GO:0016513 8.96 RUNX1 CBFB

Biological processes related to Cebpa-Associated Familial Acute Myeloid Leukemia according to GeneCards Suite gene sharing:

(show all 28)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of transcription by RNA polymerase II GO:0045944 10.04 RUNX1 NPM1 MLLT10 GATA2 ETV6 CEBPA
2 positive regulation of cell proliferation GO:0008284 10 NPM1 KRAS KIT JAK2 FLT3
3 negative regulation of gene expression GO:0010629 9.91 TERT RUNX1 PICALM GATA2
4 MAPK cascade GO:0000165 9.88 KRAS KIT JAK2 FLT3
5 positive regulation of phosphatidylinositol 3-kinase signaling GO:0014068 9.76 KIT JAK2 FLT3
6 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.72 KIT JAK2 FLT3
7 regulation of hematopoietic stem cell differentiation GO:1902036 9.7 RUNX1 GATA2 CBFB
8 negative regulation of transcription by RNA polymerase II GO:0000122 9.7 RUNX1 NSD1 GATA2 ETV6 DNMT3A CEBPA
9 positive regulation of MAP kinase activity GO:0043406 9.65 KRAS KIT FLT3
10 cytokine-mediated signaling pathway GO:0019221 9.65 KRAS KIT JAK2 FLT3 CEBPA
11 interleukin-6-mediated signaling pathway GO:0070102 9.64 JAK2 CEBPA
12 regulation of keratinocyte differentiation GO:0045616 9.63 RUNX1 CBFB
13 definitive hemopoiesis GO:0060216 9.63 GATA2 CBFB
14 regulation of regulatory T cell differentiation GO:0045589 9.62 RUNX1 CBFB
15 regulation of intracellular estrogen receptor signaling pathway GO:0033146 9.62 RUNX1 CBFB
16 hematopoietic stem cell proliferation GO:0071425 9.61 RUNX1 ETV6
17 regulation of bicellular tight junction assembly GO:2000810 9.59 RUNX1 CBFB
18 regulation of B cell receptor signaling pathway GO:0050855 9.57 RUNX1 CBFB
19 regulation of myeloid cell differentiation GO:0045637 9.56 RUNX1 CBFB
20 lymphocyte differentiation GO:0030098 9.54 FLT3 CBFB
21 regulation of cytokine-mediated signaling pathway GO:0001959 9.51 RUNX1 CBFB
22 cell maturation GO:0048469 9.5 GATA2 CEBPA CBFB
23 ribosomal small subunit export from nucleus GO:0000056 9.46 NUP214 NPM1
24 positive regulation of protein localization to nucleolus GO:1904751 9.43 TERT NPM1
25 positive regulation of CD8-positive, alpha-beta T cell differentiation GO:0043378 9.4 RUNX1 CBFB
26 negative regulation of CD4-positive, alpha-beta T cell differentiation GO:0043371 9.37 RUNX1 CBFB
27 myeloid progenitor cell differentiation GO:0002318 9.13 MLF1 KIT FLT3
28 hemopoiesis GO:0030097 9.02 RUNX1 PICALM KIT GATA2 FLT3

Molecular functions related to Cebpa-Associated Familial Acute Myeloid Leukemia according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 DNA binding GO:0003677 9.91 TERT RUNX1 MLLT10 MLF1 GATA2 ETV6
2 DNA-binding transcription factor activity GO:0003700 9.8 RUNX1 MLLT10 GATA2 ETV6 CEBPA CBFB
3 RNA polymerase II proximal promoter sequence-specific DNA binding GO:0000978 9.63 RUNX1 NSD1 GATA2 ETV6 DNMT3A CEBPA
4 protein binding GO:0005515 9.62 TERT SH3GL1 RUNX1 PICALM NUP214 NSD1
5 chromatin binding GO:0003682 9.43 NSD1 NPM1 MLLT10 GATA2 DNMT3A CEBPA

Sources for Cebpa-Associated Familial Acute Myeloid Leukemia

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....